Register for Your Free Live Webinar Now:

"The Value of CRO Team Continuity"

Register for this Webinar to Learn More

Early phase development is often treated as a series of discrete studies, but in reality, First-in-Human through Proof-of-Concept represents a single, continuous scientific and operational narrative. Each protocol, cohort, and decision builds directly on what came before. Yet across the industry, sponsors frequently experience leadership and team handoffs as programs advance—introducing risk, rework, and loss of critical context at the exact moment programs become more complex and valuable. As programs move toward Phase 1b/2, sponsors are increasingly questioning whether fragmented execution models can truly support confident, timely decision-making.

This discussion will examine why continuity across the full delivery team—project leadership, monitoring, and study management—is a foundational execution strategy in early development.

Key Takeaways

• How continuity supports scalability into Phase 1b/2 and multi-site studies
• Tenure as a credibility signal
• The operational and scientific risk introduced by team handoffs
• Why sponsors value continuity of leadership and execution teams from FIH to PoC
• What full-service early phase truly means beyond a CPU

This webinar is designed for clinical operations, development, and outsourcing leaders responsible for early-phase programs who want to reduce execution risk and maintain momentum from First-in-Human through Proof-of-Concept.

Offered Free by: Dr. Vince Clinical Research
See All Resources from: Dr. Vince Clinical Research